Neogen Chemicals Ltd logo

Neogen Chemicals Ltd

NEOGEN NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹6,673 Cr
Volatility
Moderate
P/E Ratio
175.74
EBITDA
₹143 Cr
Return on Equity
3.52%
Debt to Equity
1.71
Book Value
₹356.91
EPS
₹14.17
52W High
₹2,374
52W Low
₹966.7

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Neogen Chemicals Ltd insights

50 extracted metrics + investor summaries across FY14–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

3
  • Promoter holding has increased by 1.78% over last quarter.
  • Company's median sales growth is 20.3% of last 10 years
  • Company's working capital requirements have reduced from 112 days to 84.6 days

Weaknesses

7
  • Stock is trading at 7.53 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 4.90% over last 3 years.
  • Company might be capitalizing the interest cost
  • Dividend payout has been low at 13.6% of profits over last 3 years
  • Company has high debtors of 161 days.
  • Promoter holding has decreased over last 3 years: -7.18%

Growth Rate

Revenue Growth
11.07% ↗
Net Income Growth
-17.24% ↘
Cash Flow Change
-218.11% ↘
ROE
-20.18% ↘
ROCE
-30.32% ↘
EBITDA Margin (Avg.)
-7.97% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 43d ago
AI opinion · based on fundamentals
Risk high

Neogen Chemicals trades at a market cap of Rs 5,396 crore with a PE of 187.3x, reflecting steep premium valuation despite a TTM profit decline of 34%. The company has a strong 10-year sales CAGR of 24% but recent profitability has deteriorated with ROE falling to 4% last year, while working capital efficiency has improved from 112 days to 84.6 days.

Bull Case 7
  • Strong long-term revenue track record with 10-year compounded sales growth of 24% and median sales growth of 20.3% over last 10 years
  • Promoter holding increased by 1.78% in the most recent quarter, signaling insider confidence at current levels
  • Working capital requirements reduced from 112 days to 84.6 days, indicating improved operational efficiency
  • 5-year compounded sales growth of 21% demonstrates sustained demand for the company's lithium and bromine-based specialty chemicals
  • TTM revenue growth of 11% shows the company continues to grow top-line even in a challenging profitability environment
  • Stock has delivered 1-year price CAGR of 22%, reflecting market recognition of growth potential
  • 10-year compounded profit growth of 19% shows the company has historically been able to convert revenue growth into earnings over full cycles
Bear Case 8
  • PE ratio of 187.3x is extremely elevated, pricing in significant future growth that may not materialize given recent profit declines
  • TTM profit has declined 34% and 3-year compounded profit growth is negative at -17%, indicating a sustained earnings deterioration
  • ROE has fallen to just 4% last year versus 9% on a 10-year average, reflecting poor capital efficiency
  • Stock trades at 6.36x book value (PB of 5.51x per screener) despite delivering only 4.9% ROE over 3 years, a significant valuation-returns mismatch
  • Debtor days stand at 161 days, indicating significant working capital locked in receivables and potential collection risk
  • Low interest coverage ratio suggests debt servicing burden is consuming a meaningful share of operating profits
  • Promoter holding has decreased by 7.18% over the last 3 years despite the recent quarterly increase, showing a longer-term dilution trend
  • Dividend payout of just 10.5% of profits over the last 3 years provides negligible income return with dividend yield at only 0.05%

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 43d ago
Headwinds 1
  • Promoter pledges 13.19 lakh shares Jun 17

    Dr. Harin Kanani pledged 13,19,083 equity shares on March 30, 2026, disclosed under SEBI takeover regulations. Promoter pledging can signal financial stress or margin requirements.

Neutral 1
  • Analyst meet scheduled Jun 23 Jun 12

    Neogen Chemicals management will participate in an analyst meeting on June 23, 2026, at Grand Hyatt, Mumbai, covering business overview and financial outlook.

TL;DR: Limited news flow for Neogen Chemicals this period. The promoter share pledge of 13.19 lakh shares is a mild governance concern worth monitoring, though not uncommon among mid-cap promoters. The upcoming analyst meet on Jun 23 could provide fresh catalysts or clarity on growth outlook. Overall, the newsflow is thin and the trend is neutral pending more operational or financial updates.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
165
162
164
200
180
193
201
203
187
209
220
247
250
Expenses
137
136
144
164
149
159
167
166
155
179
188
203
202
Operating Profit
28
26
20
36
31
35
35
36
32
30
32
44
48
OPM %
17%
16%
12%
18%
17%
18%
17%
18%
17%
14%
14%
18%
19%
Other Income
2
2
2
2
2
1
1
-13
1
2
2
1
4
Interest
11
11
11
10
10
13
13
12
13
19
22
21
21
Depreciation
5
6
6
6
7
7
7
7
6
7
7
8
8
PBT
14
11
6
22
16
15
15
4
14
5
6
16
23
Tax %
28%
28%
81%
25%
27%
29%
34%
35%
28%
35%
36%
28%
26%
Net Profit
10
8
1
17
11
11
10
2
10
3
4
11
17
EPS in Rs
3.91
3.18
0.4
6.42
4.35
4.15
3.79
0.91
3.89
1.28
1.4
4.32
6.25
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
84
100
110
161
239
306
336
487
686
691
778
862
926
Expenses
71
86
90
132
196
248
272
401
575
581
641
725
772
Operating Profit
13
14
20
29
43
58
64
87
112
110
136
137
154
OPM %
15%
14%
18%
18%
18%
19%
19%
18%
16%
16%
18%
16%
17%
Other Income
1
0
0
1
1
0
1
1
5
8
-10
6
9
Interest
5
5
8
10
12
12
14
19
29
42
48
75
83
Depreciation
1
1
1
2
3
5
7
12
16
23
28
28
30
PBT
8
8
12
17
29
41
44
57
71
53
50
41
50
Tax %
37%
39%
33%
37%
28%
30%
29%
22%
30%
32%
31%
30%
—
Net Profit
5
5
8
11
21
29
31
45
50
36
35
29
36
EPS in Rs
11.31
2.59
3.84
5.49
10.43
12.28
13.43
17.9
20.04
13.51
13.2
10.9
13.25
Div. Payout %
18%
17%
0%
18%
14%
16%
17%
15%
15%
15%
8%
18%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
20
20
20
20
23
23
25
25
26
26
26
Reserves
19
8
22
30
50
133
160
414
458
734
763
790
Borrowings
24
26
69
82
120
137
222
229
370
409
597
1,395
Other Liabilities
21
26
41
48
56
61
87
131
202
292
361
691
Total Liabilities
69
80
152
180
246
355
492
799
1,054
1,461
1,747
2,902
Fixed Assets
13
17
56
67
83
111
127
285
347
496
404
475
CWIP
0
1
1
1
0
3
115
11
36
109
156
857
Investments
0
0
0
0
1
1
1
82
77
0
0
0
Other Assets
55
62
94
112
163
241
250
422
594
856
1,187
1,570
Total Assets
69
80
152
180
246
355
492
799
1,054
1,461
1,747
2,902
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
9
9
0
12
-4
-35
84
1
-30
-29
196
-231
Investing
-2
-4
-33
-13
-20
-29
-135
-146
-94
-216
-317
-410
Financing
-6
-4
33
0
24
63
51
188
100
237
113
642
Net Cash Flow
1
0
1
-1
0
-1
0
44
-25
-8
-8
0
Free Cash Flow
7
4
-33
-1
-24
-63
-51
-65
-134
-332
-121
-647
CFO/OP
89
83
21
55
4
-38
146
13
-17
-18
153
-154
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
78
58
107
94
93
90
85
82
94
149
94
161
Inventory Days
178
190
228
192
188
257
211
258
275
365
267
445
Days Payable
120
130
177
141
111
71
122
131
147
138
227
346
Cash Conversion Cycle
136
117
158
145
169
276
174
209
223
376
134
260
Working Capital Days
140
126
174
48
63
95
66
111
79
129
123
85
ROCE %
27%
26%
23%
23%
26%
22%
17%
14%
13%
9%
9%
6%

Shareholding Pattern

As of Jun 2026
Promoters 53.01%
DIIs 19.60%
Public 16.44%
Others 6.85%
FIIs 4.11%
Total 100.01%
  Mar 2021Jun 2021Sep 2021Dec 2021Jan 2022Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Nov 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Apr 2026Jun 2026
Promoters
64.33%
64.33%
64.33%
64.33%
60.19%
60.19%
60.19%
60.19%
60.19%
60.18%
60.18%
60.18%
56.89%
56.89%
56.89%
56.89%
51.23%
51.23%
51.23%
51.23%
51.23%
51.23%
51.23%
53.01%
53.01%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
4.24%
0.00%
4.51%
4.56%
4.65%
8.17%
7.73%
7.79%
7.36%
5.15%
4.57%
4.46%
4.29%
4.11%
DIIs
13.89%
13.18%
13.75%
13.48%
17.19%
17.50%
18.20%
19.12%
18.88%
20.01%
19.88%
20.25%
23.17%
22.84%
22.14%
22.54%
22.48%
22.53%
22.75%
22.96%
25.23%
21.99%
22.64%
21.66%
19.60%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
13.08%
13.31%
13.64%
13.94%
13.04%
12.87%
11.92%
10.76%
11.33%
11.58%
11.56%
11.17%
10.51%
11.76%
12.50%
11.82%
13.00%
13.22%
12.89%
12.97%
12.64%
15.30%
15.11%
14.67%
16.44%
Others
8.70%
9.18%
8.28%
8.26%
9.58%
9.44%
9.69%
9.93%
9.60%
8.23%
8.38%
4.16%
9.43%
3.99%
3.91%
4.10%
5.13%
5.29%
5.35%
5.48%
5.75%
6.90%
6.56%
6.37%
6.85%
No. of Shareholders
0
18,578
25,346
27,554
34,230
34,236
39,626
38,642
40,926
51,686
47,581
45,300
44,787
47,018
48,356
46,698
46,470
47,651
46,104
46,321
45,710
47,884
54,332
56,329
61,988

Documents

Frequently Asked Questions about Neogen Chemicals Ltd

What does Neogen Chemicals Ltd do?
Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]
Where is Neogen Chemicals Ltd (NEOGEN) listed?
Neogen Chemicals Ltd is listed on the Indian stock exchanges. It is listed on NSE: NEOGEN and BSE: 542665. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Neogen Chemicals Ltd belong to?
Neogen Chemicals Ltd operates in the Chemicals sector within the Specialty Chemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Neogen Chemicals Ltd?
Neogen Chemicals Ltd has a market capitalisation of approximately ₹6672.91 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Neogen Chemicals Ltd?
The Price-to-Earnings (PE) ratio of Neogen Chemicals Ltd is 175.74. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Neogen Chemicals Ltd?
Over the past 52 weeks, Neogen Chemicals Ltd has traded between a low of ₹966.7 and a high of ₹2,374. This range helps investors understand the stock's price volatility and recent trading levels.
Does Neogen Chemicals Ltd pay dividends?
Yes, Neogen Chemicals Ltd has a dividend yield of 0.04%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Neogen Chemicals Ltd?
Neogen Chemicals Ltd has a Return on Equity (ROE) of 3.52%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Neogen Chemicals Ltd on Tapetide?
On Tapetide, you can view Neogen Chemicals Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Neogen Chemicals Ltd, incorporated in 1991, manufactures bromine and lithium-based organic and organo-metallic compounds, used in the pharmaceutical, agricultural chemicals, and engineering industries. [1]

Website neogenchem.com
CEO Dr. Harin Haridas Kanani Ph.D.
Employees 779
Listed 2019-05-08
Face Value ₹ 10
Issued Size 2,63,81,674

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List